Patient-Selection of a Clinical Trial Primary Outcome: The ENHANCE-AF Outcomes Survey
Individuals with atrial fibrillation preferred the DCS over the DRS for measuring their decision-making experiences. As a result of this survey, the DCS was designated as the ENHANCE-AF clinical trial's primary endpoint.
Authors
- Amy Lin (ORCID: https://orcid.org/0000-0002-0760-0530)
- Randall S. Stafford (ORCID: https://orcid.org/0000-0003-1805-1271)
- Rushil Shah (ORCID: https://orcid.org/0000-0002-8218-0206)
- Karma Lhamo
- Julio C. Nunes (ORCID: https://orcid.org/0000-0001-9622-3361)
- Mellanie True Hills (ORCID: https://orcid.org/0000-0001-8298-4418)
- Katie DeSutter
- Paul J. Wang (ORCID: https://orcid.org/0000-0002-5467-5877)
- Ying Lü (ORCID: https://orcid.org/0000-0002-7698-8962)
- Bryant Lin (ORCID: https://orcid.org/0000-0002-7284-0522)
- Eli Rice (ORCID: https://orcid.org/0000-0001-9729-1251)
Institutions
- Yale University (US)
- Center for Clinical Research (United States) (US)
- Stanford University (US)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-03-07
- DOI
- https://doi.org/10.1371/journal.pone.0318858
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- American Heart Association